AccessibilityHelpAbout Us
Thc Farmaceuticals logo

Thc Farmaceuticals(OTC) CBDG

Market Cap$435.20KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2014)-98%
5 Year-34%
1 Year+4%
1 Month-14%
$0.02
+0.00%
+0.00Today
Thc Farmaceuticals last closing stock price
MetricPriceDate
Last closeUSD 0.022026-09-15
Thc Farmaceuticals stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+166.67%USD 0.012026-09-04
1 month-13.98%USD 0.032026-08-06
3 month+118.18%USD 0.012026-06-16
Year to date-36.84%USD 0.042025-12-30
1 year+4.35%USD 0.022025-09-15
3 year+140%USD 0.012023-09-15
5 year-34.07%USD 0.042021-09-15
Since inception-98.4%USD 1.502014-02-19

Thc Farmaceuticals Financials at a Glance

Market Cap

$435.20KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$15.03K

Net Income (TTM)

$48.13K

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

44.28 (High)

Price

$0.02

Volume

415

Open

$0.02

Previous Close

$0.02

Daily Range

$0.02 - $0.02

52-Week Range

$0.00 - $0.09

Estimated Earnings Date

N/A

CBDG News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Thc Farmaceuticals

THC Farmaceuticals, Inc. is a biotechnology company focused on the ownership and operation of independent automated teller machines (ATMs). The company strategically places these cash-dispensing units in high-traffic retail and commercial locations, primarily in Utah's Wasatch Front region.

Products and Services
  • Ownership and operation of independent ATMs
  • Strategic placement in high-traffic commercial areas
  • Support for small and medium-sized enterprises
Growth Outlook
  • Expansion of ATM network planned in key markets
  • Increased demand for cash access in retail environments
  • Potential partnerships with local businesses to enhance service
Financial Highlights
  • Recent quarterly revenue of $0, indicating a need for strategic financial planning
  • Trailing twelve months (TTM) net income shows a loss of $3,163
  • Current market capitalization stands at approximately $435,158
THC Farmaceuticals, Inc. operates in a niche market, providing essential cash access through ATMs in busy commercial areas. The company's focus on strategic placement aims to capture high foot traffic, which is crucial for revenue generation. Despite recent financial challenges, including a reported loss in the latest quarter, the company is positioned to explore growth opportunities through network expansion and partnerships. The current market environment presents both challenges and potential for recovery, making it an interesting prospect for investors monitoring the biotechnology sector.
AI Generated • Sep 23, 2026

Industry

Commercial Services and Supplies

Sector

Industrials

Employees

2

CEO

Mark D. Grossman

Website

www.cbdg.com

Headquarters

Scottsdale, AZ 85253, US

CBDG Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

-0.33%

Return on Capital

-0.63%

Return on Assets

-0.38%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$435.20KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

18.13M

Volume

415

Avg. Volume

311.359

Financials (TTM)

Gross Profit

$12.17K

Operating Income

-$28.97K

EBITDA

$99.12K

Operating Cash Flow

-$27.50K

Capital Expenditure

$0.00

Free Cash Flow

-$27.50K

Cash & ST Invst.

$6.87K

Total Debt

$386.30K

Thc Farmaceuticals Performance Analysis

Thc Farmaceuticals annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-09-30USD 2,234N/A
20222022-09-30USD 10,000347.6%
20232023-09-30USD 0N/A
20252025-12-31USD 0N/A
Thc Farmaceuticals sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12019-12-31N/A
Q12021-12-31N/A
Q22022-03-31-100.0%
Q32022-06-30N/A
Thc Farmaceuticals annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-09-30USD -0.00N/A
20222022-09-30USD 0.02N/A
20232023-09-30USD -0.00N/A
20252025-12-31USD -0.00-25.0%
Thc Farmaceuticals sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12019-12-31N/A
Q12021-12-31N/A
Q22022-03-31-501.5%
Q32022-06-3033.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2022YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

-$952.00

-115.1%

Gross Margin

0.00%

N/A

Market Cap

$435.20KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$217.60K

N/A

Employees

2

N/A

Net Income

-$3.16K

+99.3%

EBITDA

-$5.37K

+99.4%

Quarterly Fundamentals

Name
Q3 2022YOY CHG

Total Cash

$6.87K

+237.7%

Total Debt

$386.30K

-57.9%

Accounts Receivable

$636.22K

+2.1%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$386.30K

-57.9%

Return on Assets

-0.38%

N/A

Return on Invested Capital

-0.77%

N/A

Free Cash Flow

-$4.48K

+90.4%

Operating Cash Flow

-$4.48K

+90.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
IPIXInnovation Pharmaceuticals Inc.
$0.00+350.00%
VIRXViracta Therapeutics, Inc.
$0.01+0.00%
RASPActavia Life Sciences, Inc.
$0.00+0.00%
ENMIDH Enchantment Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
GLNDGreenland Energy
$5.54+3.55%
INTCIntel
$123.00-3.45%
NVDANvidia
$225.07+0.22%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.94-3.02%

Questions About CBDG

What is the current price of Thc Farmaceuticals?

Thc Farmaceuticals is trading at $0.02 per share.

What is the 52-week range for Thc Farmaceuticals?

Over the past 52 weeks, Thc Farmaceuticals has traded between $0.00 and $0.09.

How much debt does Thc Farmaceuticals have?

As of the most recent reporting period, Thc Farmaceuticals reported total debt of $115.27K.

How much cash does Thc Farmaceuticals have on hand?

Thc Farmaceuticals reported $0.00 in cash and cash equivalents in its most recent financial results.

What is Thc Farmaceuticals’s dividend yield?

Thc Farmaceuticals does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services